Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Clover Health Investments, Corp.
CLOV
NASDAQ·Healthcare·Medical - Healthcare Plans·Mkt cap $2.8B
$5.23
▼ -2.97%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$1.58 - $5.59
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 108.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Clover Assistant AI platform for care optimization and cost reduction
- Technology-driven approach to Medicare Advantage differentiation
- Data analytics capabilities for improved member health outcomes
- Direct-to-consumer digital engagement and enrollment
Bear Case
1 risk
- High volatility (beta 2.5). Larger-than-normal price swings expected.
Growth
Moderate growth ahead
Expanding Medicare Advantage market with aging Baby Boomer population
Value
Deep value opportunity - significant discount to Managed Care & Health Insurance peers
Momentum
Hot
+213.4% over 3m
Quality
Thin
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CLOV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 4, 2026
MAY 6, 2026
Reported EPS of $0.07 vs $0.07 consensus (0.0% surprise). Revenue of $749.2M vs $714.9M expected (+4.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
0.0%
Next: May 4, 2026
Revenue trend · last 8Q
—
—
-34%
+33%
+34%
+50%
+45%
+61%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$356.3M
$331.0M
$337.0M
$462.3M
$477.6M
$496.6M
$487.7M
$744.2M
Margins · last 8Q
Gross
—
Operating
—
Profit
3.7%
Wall Street consensus
3 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
—
Latest: UBS · Jun 11, 2026
vs Industry
How CLOV stacks vs Medical - Healthcare Plans
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related